BPCIA Litigation Updates: Amgen v. Apotex, Immunex v. Sandoz, Janssen v. Celltrion

Goodwin
Contact

A few BPCIA litigation updates to wrap up the week for our readers, looking ahead to next week:

  • The Federal Circuit issued its formal mandate in Amgen v. Apotex yesterday.  With the issuance of the formal mandate, the Federal Circuit has officially ordered that its July  opinion in the case must now be implemented.
  • The scheduling order entered in Immunex v. Sandoz yesterday reflects a stipulated preliminary injunction in the case–see the order here, and the consent preliminary injunction stipulation here.
  • The court in Janssen v. Celltrion will hear oral argument starting next Tuesday, August 16, on the Defendants’ Motion for Summary Judgment as to the ‘471 patent, the parties’ claim construction briefing for the ‘083 patent, and Plaintiffs’ Motion to Expedite Trial.

Written by:

Goodwin
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Goodwin on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide